Rapid venom immunotherapy update

Current Opinion in Allergy and Clinical Immunology

Volumn 3, Issue 4, 2003, Pages 295-298

  Scribner, Troy A ^a   Bernstein, David I ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; INSECT VENOM;

CLINICAL PROTOCOL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; INSECT STING; INTERMETHOD COMPARISON; LONG TERM CARE; PRIORITY JOURNAL; REVIEW; SYSTEMIC DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ANIMALS; ARTHROPOD VENOMS; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE H1 ANTAGONISTS; HUMANS; HYMENOPTERA; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION, PASSIVE; PREMEDICATION;

EID: 0042009731     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200308000-00010     Document Type: Review

References (19)

1. Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299:157-161.
2. Barsky HE. Stinging insect allergy. Avoidance, identification, and treatment. Postgrad Med 1987; 82:157-158; 161-162.
3. Golden DB, Valentine MD, Sobotka AK, Lichtenstein LM. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med 1980; 92:620-624.
4. Bernstein DI, Mittman RJ, Kagen SL, et al. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients. J Allergy Clin Immunol 1989; 84:951-959.
5. Birnbaum J, Charpin D, Vervloet D. Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy 1993; 23:226-230.
6. Yunginger JW, Paull BR, Jones RT, Santrach PJ. Rush venom immunotherapy program for honeybee sting sensitivity. J Allergy Clin Immunol 1979; 63:340-347.
7. van der Zwan JC, Flinterman J, Jankowski IG, Kerckhaert JA. Hyposensitisation to wasp venom in six hours. BMJ (Clin Res Ed) 1983; 287:1329-1331.
8. Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis. Ann Allergy 1994; 73:423-428.
9. Brehler R, Wolf H, Kutting B, et al. Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 2000; 105:1231-1235.
10. Lockey RF, Turkeltaub PC, Olive CA, et al. The Hymenoptera venom study. II: Skin test results and safety of venom skin testing. J Allergy Clin Immunol 1989; 84: 967-974.
11. Rueff F, Wenderoth A, Przybilla B. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol 2001; 108:1027-1032.
12. Bousquet J, Menardo JL, Velasquez G, Michel FB. Systemic reactions during maintenance immunotherapy with honey bee venom. Ann Allergy 1988; 61:63-68.
13. Reimers A, Hari Y, Muller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 2000; 55:484-488.
14. Berchtold E, Maibach R, Muller U. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 1992; 22:59-65.
15. Brockow K, Kiehn M, Riethmuller C, et al. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997; 100:458-463.
16. Sturm G, Kranke B, Rudolph C, Aberer W. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol 2002; 110:928-933. A 4-day regimen of rapid venom immunotherapy combined with a novel pretreatment regimen of an intravenous H1 blocker was successfully used to treat 101 patients with Hymenoptera anaphylaxis
17. Nielsen L, Johnsen CR, Mosbech H, et al. Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996; 97:1207-1213.
18. Muller U, Hari Y, Berchtold E. Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 2001; 107:81-86.
19. Munakata Y, Umezawa Y, Iwata S, et al. Specific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitro. Clin Exp Allergy 1999; 29:1281-1286.